Detalles de la búsqueda
1.
Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US.
Oncologist
; 29(3): e360-e371, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280190
2.
Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States.
J Thromb Thrombolysis
; 54(3): 438-448, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35562510
3.
Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S.
Oncologist
; 26(5): e817-e826, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33616256
4.
Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States.
Epilepsy Behav
; 118: 107927, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33812233
5.
Real-world genetic testing patterns in metastatic castration-resistant prostate cancer.
Future Oncol
; 17(22): 2907-2921, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906368
6.
Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation.
J Card Fail
; 25(6): 436-447, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29597052
7.
Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data.
J Asthma
; 56(8): 808-815, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30130418
8.
Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States.
Epilepsia
; 58(10): 1742-1748, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28741690
9.
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation.
Am J Hematol
; 94(2): E58-E61, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30474161
10.
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study.
Leuk Lymphoma
; : 1-11, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696747
11.
An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution".
Am J Hematol
; 93(9): E225-E227, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905381
12.
Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States.
Int J Chron Obstruct Pulmon Dis
; 18: 1575-1586, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37521022
13.
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population.
Adv Ther
; 40(3): 1224-1241, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36658454
14.
Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery Disease.
Adv Ther
; 40(4): 1850-1866, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36877443
15.
Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population.
Adv Ther
; 38(10): 5127-5143, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417724
16.
Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy.
J Comp Eff Res
; 10(16): 1235-1250, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378989
17.
Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US).
Adv Ther
; 38(7): 3771-3788, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031859
18.
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States.
J Med Econ
; 24(1): 469-478, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33784916
19.
Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population.
Curr Med Res Opin
; 37(6): 881-890, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33733969
20.
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population.
J Med Econ
; 24(1): 550-562, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33910464